首页> 外文期刊>Folia histochemica et cytobiologica >Fas/FasL expression in colorectal cancer. An immunohistochemical study.
【24h】

Fas/FasL expression in colorectal cancer. An immunohistochemical study.

机译:Fas / FasL在大肠癌中的表达。免疫组织化学研究。

获取原文
           

摘要

The objective of the current study was to assess the expression of Fas ligand (FasL) and Fas receptor (FasR) as the proteins of the post-mitochondrial apoptotic pathway in colorectal carcinoma and to investigate correlations between their expression and chosen clinico-pathological parameters. The protein expression was analyzed in 50 colorectal carcinoma patients, using the immunohistochemical method. Reaction for FasR was weak in 75.5% and strong in 24.5% of the study patients, as compared to normal glandular epithelium where FasR expression was strong in 100% of cases. On the other hand, FasL expression was found to be weak in 30% and strong in 70% of colorectal cancer patients, as compared to its lack in 100% of normal colorectal epithelium. Statistical analysis showed strong expression of FasL was found to correlate statistically significantly with vascular invasion (p = 0.005). No correlations of FasL and FasR expression in the main mass of tumor was found between other clinic-pathological parameters. Fas ligand and Fas receptor appeared to be of little usefulness as prognostic factors for different groups of colorectal carcinoma patients. However, these proteins could become good therapeutic targets for colorectal carcinoma since their expression differs distinctly between normal intestinal epithelium and cancer cells, and known is the mechanism by which cancer cells escape death via apoptosis-inducing Fas/FasL pathway disorders.
机译:本研究的目的是评估大肠癌中作为线粒体后凋亡途径蛋白的Fas配体(FasL)和Fas受体(FasR)的表达,并研究其表达与所选临床病理参数之间的相关性。使用免疫组织化学方法分析了50位大肠癌患者的蛋白表达。与正常人的腺上皮在100%的病例中FasR表达强相比,对FasR的反应在75.5%的患者中较弱,在24.5%的患者中较强。另一方面,与缺乏100%正常结直肠上皮的人相比,发现FasL表达在30%的结直肠癌患者中弱,在70%的结直肠癌患者中强。统计分析表明FasL的强表达与血管浸润在统计学上显着相关(p = 0.005)。在其他临床病理参数之间,未发现肿瘤主要肿块中FasL和FasR表达的相关性。 Fas配体和Fas受体作为不同组结直肠癌患者的预后因素似乎没有多大用处。然而,这些蛋白质可能成为结直肠癌的良好治疗靶标,因为它们的表达在正常肠上皮和癌细胞之间明显不同,并且已知癌细胞通过凋亡诱导Fas / FasL途径疾病逃脱死亡的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号